Paper8809405
Induction of apoptosis but not G1 arrest by expression of the wild-type p53 gene in small cell lung carcinoma.
Adachi J and 6 others. Cell Growth Differ, 1996. Cited by 28 papers, by iCite.
Cite this record
ConductScience Library. Induction of apoptosis but not G1 arrest by expression of the wild-type p53 gene in small cell lung carcinoma. Papers, record 8809405. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8809405
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Induction of apoptosis but not G1 arrest by expression of the wild-type p53 gene in small cell lung carcinoma.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Apoptosis | Major topic |
| Carcinoma, Small Cell | Major topic |
| G1 Phase | Major topic |
| Gene Expression Regulation, Neoplastic | Major topic |
| Lung Neoplasms | Major topic |
| Tumor Suppressor Protein p53 | Major topic |
| Gene Transfer Techniques | |
| Humans | |
| Mutation | |
| Tumor Cells, Cultured |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 26220992 | Origins, genetic landscape, and emerging therapies of small cell lung cancer. | Genes Dev | 2015 | https://conductscience.org/library/papers/26220992 | PubMed |
| 23364678 | Poly(β-amino ester) nanoparticle delivery of TP53 has activity against small cell lung cancer in vitro and in vivo. | Mol Cancer Ther | 2013 | https://conductscience.org/library/papers/23364678 | PubMed |
| 15016317 | Molecular footprints of human lung cancer progression. | Cancer Sci | 2004 | https://conductscience.org/library/papers/15016317 | PubMed |
| 12824923 | Enhanced sensitivity to cis-diamminedichloroplatinum(II) of a human carcinoma cell line with mutated p53 gene by cyclin-dependent kinase inhibitor p21(WAF1) expression. | Cancer Sci | 2003 | https://conductscience.org/library/papers/12824923 | PubMed |
| 10822369 | c-Myc antagonizes the effect of p53 on apoptosis and p21WAF1 transactivation in K562 leukemia cells. | Oncogene | 2000 | https://conductscience.org/library/papers/10822369 | PubMed |
| 10698937 | TIP30 has an intrinsic kinase activity required for up-regulation of a subset of apoptotic genes. | EMBO J | 2000 | https://conductscience.org/library/papers/10698937 | PubMed |
| 10327074 | Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells. | Oncogene | 1999 | https://conductscience.org/library/papers/10327074 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8809405
GET https://conductscience.org/api/papers/v1/8809405/authors